Inventor · disambiguated record
Yong Gong
Also filed as: GONG YONG · Gong yong-feng
20 granted patents·9 pending applications·164 citations·filing 1999–2020
93Inventor score
Files withJANSSEN PHARMACEUTICA NV19HOU JIANGHUI2ORTHO CLINICAL DIAGNOSTICS INC2AVENTIS PHARM PROD INC1BARBAY JOSEPH KENT1
Top patents by PatentIndex Score
29 records- 0195US9410972B2Antibodies to quetiapine and use thereofORTHO CLINICAL DIAGNOSTICS INC·Filed 2013·Granted Aug 9, 2016·17 cites·20 claims
- 0294US9494608B2Antibodies to olanzapine and use thereofORTHO CLINICAL DIAGNOSTICS INC·Filed 2013·Granted Nov 15, 2016·15 cites·25 claims
- 0393US6323227B1Substituted N-[(aminoiminomethyl or aminomethyl)phenyl]propyl amidesAVENTIS PHARM PROD INC·Filed 1999·Granted Nov 27, 2001·76 cites·61 claims
- 0492US9850318B2Antibodies to quetiapine haptens and use thereofJANSSEN PHARMACEUTICA NV·Filed 2013·Granted Dec 26, 2017·16 cites·15 claims
- 0591US9303041B2Haptens of olanzapineJANSSEN PHARMACEUTICA NV·Filed 2013·Granted Apr 5, 2016·17 cites·29 claims
- 0691US9304126B2Haptens of quetiapineJANSSEN PHARMACEUTICA NV·Filed 2013·Granted Apr 5, 2016·17 cites·21 claims
- 0779US9611259B2Substituted pyridine derivatives useful as C-FMS kinase inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2014·Granted Apr 4, 2017·3 cites·13 claims
- 0873US11021712B1MiRNA mimics and uses thereofHOU JIANGHUI·Filed 2019·Granted Jun 1, 2021·2 cites·11 claims
- 0971US11046786B2Antibodies to olanzapine and use thereofJANSSEN PHARMACEUTICA NV·Filed 2019·Granted Jun 29, 2021·0 cites·20 claims
- 1070US2021017294A9Antibodies to quetiapine haptens and use thereofJANSSEN PHARMACEUTICA NV·Filed 2019·Application pending·0 cites
- 1169US11214566B2Substituted pyridine derivatives useful as C-FMS kinase inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2020·Granted Jan 4, 2022·0 cites·12 claims
- 1269US2019271712A1Antibodies to quetiapine and use thereofJANSSEN PHARMACEUTICA NV·Filed 2019·Application pending·0 cites
- 1366US8809554B2Process for the preparation of sulfamide derivativesJANSSEN PHARMACEUTICA NV·Filed 2012·Granted Aug 19, 2014·1 cites·24 claims
- 1464US10712353B2Antibodies to olanzapine haptens and use thereofJANSSEN PHARMACEUTICA NV·Filed 2017·Granted Jul 14, 2020·0 cites·7 claims
- 1563US11104742B2Antibodies to quetiapine and use thereofJANSSEN PHARMACEUTICA NV·Filed 2019·Granted Aug 31, 2021·0 cites·21 claims
- 1662US11226345B2Antibodies to olanzapine haptens and use thereofJANSSEN PHARMACEUTICA NV·Filed 2017·Granted Jan 18, 2022·0 cites·15 claims
- 1762US10800764B2Substituted pyridine derivatives useful as C-FMS kinase inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2018·Granted Oct 13, 2020·0 cites·10 claims
- 1860US10071991B2Substituted pyridine derivatives useful as c-fms kinase inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2017·Granted Sep 11, 2018·0 cites·3 claims
- 1959US10465013B2Antibodies to quetiapine haptens and use thereofJANSSEN PHARMACEUTICA NV·Filed 2017·Granted Nov 5, 2019·0 cites·14 claims
- 2059US10288631B2Antibodies to quetiapine and use thereofJANSSEN PHARMACEUTICA NV·Filed 2016·Granted May 14, 2019·0 cites·12 claims
- 2158US10344098B2Antibodies to olanzapine and use thereofJANSSEN PHARMACEUTICA NV·Filed 2016·Granted Jul 9, 2019·0 cites·25 claims
- 2257US10435478B2Antibodies to quetiapine and use thereofJANSSEN PHARMACEUTICA NV·Filed 2016·Granted Oct 8, 2019·0 cites·25 claims
- 2356US2014057303A1Antibodies to Olanzapine Haptens and Use ThereofJANSSEN PHARMACEUTICA NV·Filed 2013·Application pending·0 cites
- 2448US2009048295A1Substituted 5,6,7,8-tetrahydroquinoline derivatives, compositions, and methods of use thereofBARBAY JOSEPH KENT·Filed 2008·Application pending·0 cites
- 2546US2005176755A1Aza-bridged-bicyclic amino acid derivatives as alpha4 integrin antagonistsFiled 2004·Application pending·0 cites
- 2642US2006223846A1Aza-bridged-bicyclic amino acid derivatives as alpha4 integrin antagonistsDYATKIN ALEXEY B·Filed 2006·Application pending·0 cites
- 2740US2005192279A1Pyridazinones as antagonists of alpha4 integrinsFiled 2005·Application pending·0 cites
- 2840US2005209232A1Pyridazinone ureas as antagonists of alpha4 integrinsBARBAY KENT·Filed 2005·Application pending·0 cites
- 2934US2018291377A1Blood Brain Barrier Opening Agents and Uses ThereofHOU JIANGHUI·Filed 2018·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Yong Gong files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →